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Abstract: Regular nut consumption is associated with reduced risk factors for chronic disease; however,
most population-based studies lack consideration of effect modification by dietary pattern. The UK
Women’s Cohort Study (UKWCS) provides an ideal opportunity to examine relationships between
nut consumption and chronic disease risk factors in a large sample with diverse dietary patterns.
Nut and nutrient intake from 34,831 women was estimated using a food frequency questionnaire
among self-identified omnivores, vegetarians and vegans. In this cross-sectional analysis, higher
nut consumption was associated with lower body weight (difference between highest and lowest
consumption categories from adjusted model: 6.1 kg; 95% CI: 4.7, 7.6) body mass index (BMI, 2.4 units
difference; 95% CI: 1.9, 2.9), and waist circumference (2.6 cm difference; 95% CI: 1.4, 3.8) (all p for linear
trend <0.001). Higher nut consumption was also associated with reduced prevalence of high cholesterol
and high blood pressure; having a history of heart attack, diabetes and gallstones; and markers of
diet quality (all adjusted p for linear trend ≤0.011). Higher nut consumption appeared overall to be
associated with greater benefits amongst omnivores compared to vegetarians and vegans. Findings
support existing literature around beneficial effects of nut consumption and suggest that benefits may
be larger among omnivores. Nut promotion strategies may have the highest population impact by
specifically targeting this group.
Keywords: nuts; predictors; cardiovascular disease risk; chronic disease risk; diabetes; cancer; vegan;
vegetarian; omnivore
1. Introduction
Nuts are rich sources of cis-unsaturated fatty acids, fibre, vitamins, minerals, and a number
of bioactive substances [1–3]. The regular consumption of nuts is associated with a reduction in
all-cause mortality [4–11], and in particular cardiovascular disease (CVD) [4–11]. Some research has
also shown that regular nut consumption is inversely associated with the incidence of cancer and
diabetes, although these findings are less consistent [4–6,8,12–16].
While the health benefits of nut consumption are well documented, a number of studies have
shown that nut intakes at the population level are far from ideal [17–20]. For example, data from the
European Prospective Investigation into Cancer and Nutrition (EPIC) study showed that only 6.9% of
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the population consumed whole nuts on the day of the 24-h recall, with a mean population intake
of 2.2 g/day [18]. This is similar to intakes reported in the United States of America (USA) [19] and
New Zealand (NZ) [17], where the prevalence of whole nut intake was 6.0% and 6.9% respectively on
a given day. Despite these low reported intakes, examining the predictors of nut intake is important to
provide information for public health initiatives which aim to increase regular nut consumption as
a means of reducing the risk of CVD and other chronic diseases.
Only a small number of studies have previously examined predictors of nut consumption. In the
USA [21] and NZ [17], nuts were most likely to be consumed by Caucasians with higher education and
income levels. Likewise, in the EPIC cohort [18], education level was positively associated with nut
intake. Age was also an important predictor of nut intake. In the USA, among those aged 19–51 years,
the percentage of participants consuming nuts on a given day was 5.5%, compared to 8.4% among
those aged over 51 years [21]. In NZ, the prevalence of whole nut consumption on a given day was
highest among those aged 31–70 years [17]. These studies have provided useful information on which
to base public health messages, but all are limited by the relatively low prevalence of nut intake,
which limits the complexity of statistical models investigating plausible confounders, effect modifiers,
and mediators.
The Seventh-Day Adventist study examined the associations between levels of nut consumption
and coronary heart disease (CHD) for vegetarians and non-vegetarian, finding protective associations
for both [22]. Identifying associations between nut intake and risk factors for chronic disease can also
provide important information for strategies to reduce disease risk. Studies have consistently reported
that regular nut consumption is associated with reductions in total and low-density lipoprotein (LDL)
cholesterol [23]. The evidence for effects on blood pressure is less clear. Findings from NHANES
1999–2004 indicate that nut consumers had significantly lower systolic blood pressure and prevalence
of hypertension [24]. However, in a cross-sectional analysis of a nationally representative NZ sample,
there was no evidence for a difference in systolic or diastolic blood pressure between nut consumers
and non-nut consumers [25]. Results from clinical trials also show mixed results, with the majority
reporting no evidence of any effect on blood pressure [26–29].
A more consistent finding among different populations is that lower body weight, BMI and waist
circumference are all seen among those who consume nuts in comparison to non-nut consumers.
Epidemiological studies have found that nut consumers are leaner than non-nut consumers [30–34],
which is in agreement with intervention studies which report that when nuts are added to the diet,
weight gain is either negligible or less than predicted based on energy content [34–39].
Most of the aforementioned studies have included samples where dietary intakes do not vary
widely, which can make generalising to the full range of intakes problematic, and have not been able
to consider the potential effect modification of the associations by dietary patterns. The UK Women’s
Cohort Study provides an ideal opportunity to examine a wide range of dietary patterns and the effects
of nut intakes within these patterns. Due to the high percentage of vegetarians purposefully recruited
into this cohort, nut consumption patterns are more diverse than seen in most other studies. Therefore,
we aim to identify predictors of nut intake, and identify associations between nut consumption and
chronic disease risk in a cohort of women with diverse dietary patterns.
2. Materials and Methods
2.1. Study Design and Participants
The UK Women’s Cohort Study (UKWCS) has been described in detail elsewhere [40]. In brief,
the cohort was derived from responders to a mail survey of the World Cancer Research Fund, living in
England, Wales, and Scotland. Responders willing to participate in a more detailed survey composed
the population who were then contacted to participate in the UKWCS. Eligible participants included
women aged 35 to 69 years (inclusive) who self-reported being a vegetarian or non-red-meat eaters.
A group of non-vegetarians were selected by choosing for each vegetarian the next non-vegetarian from
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the stored direct mail database who was aged within 10 years of the vegetarian. From the 61,000 women
contacted, 35,372 returned completed questionnaires, a response rate of 58%. Permission to carry out
the baseline UKWCS was obtained by 174 local research ethics committees.
2.2. Dietary Intake
Baseline dietary data were collected between 1995 and 1998 using a detailed self-administered
217-item postal food frequency questionnaire (FFQ) which was based on the European Prospective
Investigation into Cancer and Nutrition (EPIC) study and asked about food intake over the last year.
This FFQ was validated against a semi-weighed four-day record, and some biochemical measures [41],
however, not for nut intake in particular.
2.3. Nut Intake
At baseline, total nut intake was derived from the FFQ which included items on almonds, cashews,
peanuts, pecans, pistachios, and walnuts, but not including the items on nut butters or nut pates.
Total intake of nuts was calculated by summing the intakes of nuts from the individual food items,
which were determined by using the frequency categories to estimate weekly intake in terms of
servings, which were then converted to servings per day. Amounts in g were then estimated using
a serving size of 30 g [42]. Intakes in g per day were also grouped into consumption categories of
‘none’ (0 g/day), ‘less than one 30 g serving per week’ (less than 4.3 g/day), 2–6 servings per week’
(less than 30 g/day), ‘daily’ (30–59.9 g/day), and ‘more than daily’ (60 g/day or more).
2.4. Lifestyle Questionnaire
Each participant completed a self-administered lifestyle questionnaire where information was
collected on age, employment, education level, physical activity, ethnicity, menopausal status, age of
menarche, parity, use of hormone replacement therapy (HRT) and oral contraceptive pill (OCP),
smoking status, body weight, height, and waist circumference [43]. Participants self-classified as
omnivores, vegetarians, or vegans.
2.5. Statistical Analysis
For this cross-sectional analysis, participants were excluded if the data was biologically
implausible i.e., they had extremely high (>6000 kcal/day or 25,080 kJ/day) (n = 80) or low
(<500 kcal/day or 2090 kJ/day) (n = 6) energy intake, a BMI of less than 13 kg/m2 (n = 10) or
implausibly high based on discordant height and weight measures (n = 2), a waist circumference of less
than 50 cm (n = 25), or a height greater than 7 feet (213.36 cm) (n = 12). A total of 126 distinct participants
were excluded from this analysis based on these criteria. We also only included women who provided
information on nut consumption, thus a further 415 women were excluded. Thus, the final analysis
was performed on 34,831 women.
Appropriate summary statistics were calculated for all measures of interest (participant
characteristics, nut consumption, and measures of chronic disease risk), specifically means and
standard deviations (SD) for approximately normally distributed continuous variables, medians
and inter-quartile ranges (IQR) for non-normal continuous variables, and counts and percentages
for categorical variables. Linear, binary logistic, and ordinal logistic regression models were used
to identify associations with continuous, binary, and ordinal outcomes respectively. When ordinal
predictor variables were investigated (nut consumption level), orthogonal polynomials were used
to model linear and higher order trends. Linear trends are reported and while higher-order
trends are noted, these are only discussed where they affect the interpretation of results
(e.g., indicate non-monotonicity). Effect modification of associations between nut intakes and outcomes
by dietary pattern (omnivore, vegetarian, and vegan) was investigated by adding an interaction
between dietary pattern and each of the orthogonal polynomial terms for nut consumption levels.
A Wald test was used to assess the overall significance of this interaction with pairwise comparisons
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performed only when this was significant. For continuous outcomes, where model residuals were
skewed and/or heteroscedastic, log-transformations were investigated, and retained when this
improved residual behaviour. For models using dietary pattern (omnivorous, vegetarian, and vegan),
sensitivity analyses were performed using total meat servings per week. Analyses were conducted
using Stata 13.1 (StataCorp LLC, College Station, TX, USA) and two-sided p < 0.05 was considered
statistically significant.
3. Results
3.1. Participant Characteristics and Nut Consumption among the Cohort
The characteristics of all 34,831 women in the study are shown in Table 1, both overall and by
nut consumption (none versus any). Mean age (SD) was 52.2 (9.3) years with a mean (SD) BMI of
24.5 (4.3) kg/m2. In general, the cohort had a low prevalence of smoking (11%), was well educated
with over 27% with a degree, and over 50% were working in professional or managerial positions.
The majority of the cohort reported being omnivores (n = 25,116, 72%), with over one-quarter being
vegetarian (n = 9280, 27%), and 1% (n = 435) vegans.
Overall 16% of respondents reported consuming no nuts, with the 84% of participants who
consumed nuts comprising 52% of the sample estimated to consume nuts less than once per week,
28% 2–6 times per week, 3% daily, and 1% at least 2 times per day.
Compared with non-nut consumers, nut consumers appear to be slightly younger (by four years),
appreciably more physically active, leaner (by each of weight, BMI, and waist circumference),
much more likely to be highly educated, with a higher proportion working in professional or
managerial positions. Nut consumers also appear much more likely to be vegetarians and vegans,
and consume around 10 % more energy and over two-thirds more alcohol. They also appeared to be
more likely to be pre-menopausal, and use oral contraceptives, consistent with them being younger.
No practically important differences were observed between these two groups in terms of height,
smoking, age of menarche, or parity. The only substantial difference for ethnicity appeared to be
amongst those classified as Asian who had around four times the odds of consuming nuts compared
to those classified as White. It should be noted that the number of Asian participants was small.
Table 1. Characteristics of study participants by nut consumption.
Demographic Variable All Participants *(n = 34,831)
Non-Nut Consumers
(n = 5631)
Nut Consumers
(n = 29,200)
Age (years) a 52.2 (9.3) 55.5 (9.6) 51.6 (9.1)
Height (cm) a 163.7 (6.8) 163.1 (6.8) 163.8 (6.7)
Weight (kg) a 65.6 (11.9) 67.4 (13.2) 65.3 (11.6)
BMI (kg/m2) a 24.5 (4.3) 25.3 (4.7) 24.3 (4.1)
Waist circumference (cm) a 73.6 (9.3) 75.0 (10.3) 73.3 (9.0)
Physical activity b
None 42.2 (13,934) 52.9 (2769) 40.2 (11,165)
<75 min/week 20.0 (6606) 14.1 (738) 21.1 (5868)
75 min/week or more 37.7 (12,448) 33.0 (1725) 38.6 (10,723)
Ethnicity b
White 96.0 (33,432) 95.9 (5400) 96.0 (28,032)
Asia 0.5 (188) 0.1 (8) 0.6 (180)
Black 0.1 (50) 0.1 (6) 0.2 (44)
Other 3.3 (1161) 3.9 (217) 3.2 (944)
Employment b
Professional 24.7 (8590) 18.2 (1024) 25.9 (7566)
Managerial, technical, admin 28.7 (9994) 23.9 (1346) 29.6 (8648)
Clerical/Skilled 41.2 (14,338) 49.0 (2760) 39.7 (11,578)
Manual 1.0 (344) 1.6 (89) 0.9 (255)
Other/missing/no job 4.5 (1565) 7.3 (412) 4.0 (1153)
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Table 1. Cont.
Demographic Variable All Participants *(n = 34,831)
Non-Nut Consumers
(n = 5631)
Nut Consumers
(n = 29,200)
Highest educational achievement b
No qualifications 16.8 (5347) 30.2 (1507) 14.3 (3840)
O-level (16 years) 31.2 (9940) 33.8 (1688) 30.7 (8252)
A-level (18 years) 24.7 (7859) 20.2 (1009) 25.5 (6850)
Degree 27.4 (8718) 15.9 (794) 29.5 (7924)
Dietary pattern b
Omnivore 72.1 (25,116) 83.1 (4679) 70.0 (20,437)
Vegetarian 26.6 (9280) 16.1 (905) 28.7 (8375)
Vegan 1.3 (435) 0.8 (47) 1.3 (388)
Energy intake (kJ/day) a 9817 (2986) 9029 (2954) 9969 (2986)
Alcohol
consume any alcohol b 89.6 (29,848) 80.4 (4302) 91.3 (25,546)
g/day among alcohol consumers c 6.7 (11.8) 4.1 (10.1) 7.0 (12.1)
Smoking status b
Never smoked 57.9 (19,535) 58.8 (3186) 57.7 (16,349)
Current smoker 11.1 (3739) 12.1 (657) 10.9 (3082)
Former smoker 31.1 (10,486) 29.1 (1580) 31.4 (8906)
Menopausal status b
Premenopausal 47.6 (15,859) 33.0 (1768) 50.4 (14,091)
Postmenopausal 52.4 (17,462) 67.0 (3586) 49.6 (13,876)
Current HRT use (%) b 23.2 (7539) 23.1 (1195) 23.2 (6344)
Current OCP use (%) b 3.9 (1294) 3.2 (166) 4.1 (1128)
Age of menarche (year) a 12.8 (1.6) 12.8 (1.7) 12.8 (1.6)
Parity b
no children 13.6 (4258) 13.3 (667) 13.7 (3591)
1–2 children 65.9 (17,775) 55.6 (2790) 57.2 (14,985)
3–4 children 27.1 (8449) 27.9 (1399) 26.9 (7050)
≥5 children 2.3 (724) 3.2 (162) 2.2 (562)
* Included only participants with data on nut consumption (n = 34,831); a values are presented as means
(standard deviations); b values are presented as % (number); c values are presented as medians (IQR); abbreviations:
BMI, body mass index; HRT, hormone replacement therapy; OCP, oral contraceptive pill.
3.2. Predictors of Nut Consumption
Table 2 reports the unadjusted and adjusted odds ratios (OR) for frequency of consuming nuts
(5 ordinal levels from none to more than daily) from ordinal logistic regression modes using selected
demographic variables as predictors. Nut consumption levels were statistically significantly lower with
greater age. Compared with those aged in their forties, those aged in their fifties, sixties and seventies
were less likely to consume higher quantities of nuts. There was a statistically significant association
between nut consumption and physical activity, with those who performed no vigorous physical
activity less likely to consume higher amounts of nuts than those who performed some vigorous
activity. Those working in professional positions were more likely to consume greater quantities of
nuts compared to those in clerical or skilled positions. The percentage consuming nuts was statistically
significantly greater for those with higher educational qualifications, where those with a degree had
2.26 times the odds (95% CI: 2.07, 2.46; p < 0.001) of consuming greater amounts of nuts compared
to those with no education. Former smokers were more likely to consume higher quantities of nuts
compared to both current smokers and those who have never smoked.
Both vegetarians (OR: 2.23; 95% CI: 2.12, 2.35; p < 0.001) and vegans (OR: 3.76; 95% CI: 3.05, 4.64;
p < 0.001) were statistically significantly more likely to consume higher amounts of nuts compared to
omnivores, In a model also adjusting for energy intake, this association remained and higher energy
intakes were associated with greater likelihoods of consuming higher quantities of nuts (p < 0.001).
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Table 2. Predictors of nut consumption *.
Demographic Variable
Total Nut Consumption
Unadjusted OR †
Unadjusted
p-Value Adjusted OR
†,‡ Adjusted p-Value ‡No Nuts
(n = 5631)
<Once per Week
(n = 17,992)
2–6 Times per Week
(n = 9887) Daily (n = 995) >Daily (n = 326)
Age (years) OR per 5 years 1 55.5 (55.3, 55.8) 51.8 (51.7, 52.0) 51.0 (50.8, 51.2) 53.3 (52.7, 53.9) 54.1 (53.1, 55.2) <0.001 <0.001
OR for 50 vs. 40 0.84 (0.83, 0.85) 0.95 (0.93, 0.97)
OR for 60 vs. 40 0.65 (0.63, 0.67) 0.88 (0.84, 0.92)
OR for 70 vs. 40 0.45 (0.42, 0.48) 0.79 (0.73, 0.86)
Physical activity 2
None 52.9 (2769) 42.5 (7262) 36.4 (3436) 36.6 (348) 38.8 (119) 1.00 a <0.001 1.00 a <0.001
<75 min/week 14.1 (738) 20.8 (3543) 21.8 (2054) 21.7 (206) 21.2 (65) 1.54 (1.45, 1.62) b 1.31 (1.24, 1.40) b
75 min/week or more 33.0 (1725) 36.7 (6264) 41.8 (3940) 41.7 (396) 40.1 (123) 1.47 (1.41, 1.54) b 1.29 (1.23, 1.36) b
Employment 2 <0.001 <0.001
Professional 18.2 (1024) 24.3 (4370) 28.3 (2794) 32.5 (323) 24.2 (79) 1.00 a 1.00 a
Managerial, technical, admin 23.9 (1346) 28.5 (5133) 31.7 (3138) 29.0 (289) 27.0 (88) 0.90 (0.85, 0.95) b 1.12 (1.05, 1.19) b
Clerical/Skilled 49.0 (2760) 42.1 (7580) 35.6 (3514) 34.4 (342) 43.6 (142) 0.63 (0.60, 0.66) c 1.01 (0.94, 1.08) a
Manual 1.6 (89) 1.0 (183) 0.7 (67) 0.2 (2) 0.9 (3) 0.42 (0.35, 0.52) d 0.87 (0.68, 1.10) a,b
other/missing/no job 7.3 (412) 4.0 (726) 3.8 (374) 3.9 (39) 14 (4.3%) 0.51 (0.46, 0.56) d 0.91 (0.80, 1.04) a
Highest educational achievement (%) 2 <0.001 <0.001
no qualifications 30.2 (1507) 16.1 (2656) 11.0 (1008) 13.0 (120) 18.4 (56) 1.00 a 1.00 a
O-level (16 years) 33.8 (1688) 32.8 (5404) 27.5 (2529) 25.4 (234) 28.0 (85) 1.66 (1.55, 1.77) b 1.41 (1.31, 1.52) b
A-level (18 years) 20.2 (1009) 24.9 (4092) 26.7 (2456) 24.5 (226) 25.0 (76) 2.24 (2.09, 2.39) c 1.87 (1.73, 2.03) c
Degree 15.9 (794) 26.2 (4302) 34.8 (3194) 37.0 (341) 28.6 (87) 2.98 (2.78, 3.18) d 2.26 (2.07, 2.46) d
Dietary status 2 <0.001 <0.001
Omnivore 83.1 (4679) 77.4 (13,931) 59.3 (5861) 50.9 (506) 42.6 (139) 1.00 a 1.00 a
Vegetarian 16.1 (905) 21.9 (3932) 38.7 (3823) 45.7 (455) 50.6 (165) 2.51 (2.40, 2.63) b 2.23 (2.12, 2.35) b
Vegan 0.8 (47) 0.7 (12) 2.1 (203) 3.4 (34) 6.8 (22) 4.06 (3.36, 4.89) c 3.76 (3.05, 4.64) c
Energy intake (kJ/day) 1 9029 (8952, 9107) 9474 (9434, 9514) 10,565 (10,505, 10,642) 11,819 (11,610, 12,028) 13,596 (13,170, 14,022) <0.001
OR for 4 MJ vs. 10 MJ 0.31 (0.29, 0.32)
OR for 6 MJ vs. 10 MJ 0.49 (0.47, 0.50)
OR for 8 MJ vs. 10 MJ 0.71 (0.70, 0.72)
OR for 12 MJ vs. 10 MJ 1.36 (1.34, 1.38)
OR for 14 MJ vs. 10 MJ 1.80 (1.75, 1.85)
OR for 16 MJ vs. 10 MJ 2.34 (2.25, 2.43)
Smoking status 2
Never smoked 58.8 (3186) 57.9 (10,132) 57.2 (5482) 57.3 (545) 61.5 (190) 1.00 a <0.001 1.00 a <0.001
Current smoker 12.1 (657) 11.0 (1928) 10.8 (1034) 9.8 (93) 8.7 (27) 0.94 (0.88, 1.00) a 0.98 (0.91, 1.05) a
Former smoker 29.1 (1580) 31.0 (5430) 32.0 (3071) 32.9 (313) 29.8 (92) 1.07 (1.02, 1.12) b 1.07 (1.02, 1.12) b
* Included participants with data on nut consumption (n = 34,831); 1 Values are presented as means (95% CI); 2 values are presented as % (number); † calculated using ordinal logistic
regression with fractional polynomials used for continuous variables; ‡ adjusted for all other variables in the table except for energy intake; MJ, Megajoule; OR, Odds ratio. Odds ratios
with different superscript letters (e.g., a and b) are significantly different.
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3.3. Nut Consumption and Anthropometric Measures
In all unadjusted and adjusted models, for body weight, BMI and waist circumference there was
evidence of a linear trend where higher nut consumption levels were associated with lower values
(adjusted differences between the highest compared to lowest consumption categories, including
total energy in the models: 6.1 kg (95% CI: 4.7, 7.6), 2.4 BMI units (95% CI: 1.9, 2.9), and 2.6 cm
(95% CI: 1.4, 3.8), all p for linear trend <0.001 (Table 3).
3.4. History of Selected Chronic Diseases and Risk Factors for Chronic Disease by Nut Consumption
For two risk factors for chronic disease, namely, high blood pressure (for highest compared to
lowest consumption category unadjusted OR: 0.54 (95% CI: 0.40, 0.76) and adjusted for variables
other than BMI, which could be on the causal pathway as well as potentially a confounder, OR: 0.69
(95% CI: 0.48, 0.98) and high blood cholesterol (unadjusted OR: 0.57 (95% CI: 0.36, 0.90) and adjusted
OR: 0.67 (95% CI: 0.40, 1.14)) there was evidence in all models for a linear trend where higher levels
of nut consumption was associated with lower prevalence of these risk factors (all p for linear trend
≤0.010 for high blood pressure and ≤0.004 for high blood cholesterol) (Table 4).
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Table 3. Anthropometric measures by nut consumption category.
Anthropometry Variable
Total Nut Consumption p for Linear
Trend
Unadjusted †
p for Linear
Trend
Adjusted †,‡
p for Linear trend
Further Adjusted for
Energy Intake †,‡
All Participants
(n = 34,831)
No Nuts
(n = 5631)
<Once per Week
(n = 17,992)
2–6 Times per
Week (n = 9887) Daily (n = 995) >Daily (n = 326)
Weight (kg) 65.6 (65.5, 65.7) 67.4 (67.1, 67.8) 66.2 (66.0, 66.4) 64.0 (63.8, 64.3) 61.7 (63.8, 64.3) 60.6 (59.5, 61.7) <0.001 § <0.001 § <0.001 §
BMI (kg/m2) 24.5 (24.4, 24.5) 25.3 (25.2, 25.4) 24.7 (24.7, 24.8) 23.7 (23.6, 23.9) 22.8 (22.6, 23.1) 22.5 (22.2, 22.9) <0.001 § <0.001 § <0.001 §
Waist circumference (cm) 73.6 (73.5, 73.7) 75.0 (74.7, 75.3) 73.8 (73.6, 74.0) 72.5 (72.3, 72.7) 72.2 (71.6, 72.8) 72.1 (71.1, 73.2) <0.001 § <0.001 <0.001 §
Values are presented as means (95% CI); † calculated using orthogonal polynomials; ‡ adjusted for age, vigorous physical activity category, dietary pattern, job category, and smoking
status; § there was statistical significant evidence for a quadratic or higher order trend.
Table 4. Odds ratio (95%CI) for chronic disease and risk factors for chronic disease by nut consumption.
Disease/Risk Factor Variable
Total Nut Consumption
p for Linear Trend †No Nuts
(n = 5631)
<Once per Week
(n = 17,992)
2–6 Times per Week
(n = 9887) Daily (n = 995) >Daily (n = 326)
High Blood Pressure
Cases 1190 2945 1329 144 44
Unadjusted 1.00 0.70 (0.65, 0.75) 0.55 (0.51, 0.60) 0.60 (0.5, 0.73) 0.54 (0.40, 0.76) <0.001
Adjusted for age only 1.00 0.86 (0.80, 0.93) 0.71 (0.65, 0.78) 0.68 (0.56, 0.83) 0.57 (0.41, 0.80) <0.001
Adjusted ‡ 1.00 0.85 (0.78, 0.93) 0.75 (0.67, 0.83) 0.72 (0.58, 0.90) 0.69 (0.48, 0.98) <0.001
Further adjusted for BMI 1.00 0.86 (0.78, 0.93) 0.82 (0.74, 0.91) 0.90 (0.72, 1.12) 0.92 (0.63, 1.34) 0.010
High cholesterol
Cases 547 1261 564 58 20
Unadjusted ‡ 1.00 0.66 (0.60, 0.74) 0.53 (0.47, 0.60) 0.54 (0.41, 0.72) 0.57 (0.36, 0.90) <0.001
Adjusted for age only 1.00 0.87 (0.78, 0.97) 0.73 (0.64, 0.83) 0.63 (0.47, 0.83) 0.62 (0.38, 0.99) <0.001
Adjusted ‡ 1.00 0.84 (0.74, 0.95) 0.75 (0.65, 0.87) 0.70 (0.51, 0.96) 0.67 (0.40, 1.14) <0.001
Further adjusted for BMI 1.00 0.85 (0.75, 0.96) 0.78 (0.67, 0.91) 0.78 (0.57, 1.08) 0.76 (0.44, 1.32) 0.004
Heart Attack
Cases 151 212 101 17 2
Unadjusted 1.00 0.41 (0.33, 0.51) 0.35 (0.27, 0.46) 0.59 (0.36, 0.99) 0.21 (0.05, 0.86) <0.001
Adjusted for age only 1.00 0.59 (0.47, 0.73) 0.55 (0.42, 0.72) 0.73 (0.44, 1.22) 0.23 (0.06, 0.94) <0.001
Adjusted ‡ 1.00 0.56 (0.44, 0.72) 0.51 (0.37, 0.69) 0.70 (0.38, 1.26) 0.28 (0.07, 1.15) <0.001
Further adjusted for BMI 1.00 0.56 (0.44, 0.72) 0.55 (0.40, 0.75) 0.82 (0.45, 1.49) 0.36 (0.09, 1.51) 0.011
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Table 4. Cont.
Disease/Risk Factor Variable
Total Nut Consumption
p for Linear Trend †No Nuts
(n = 5631)
<Once per Week
(n = 17,992)
2–6 Times per Week
(n = 9887) Daily (n = 995) >Daily (n = 326)
Angina
Cases 206 314 144 20 9
Unadjusted 1.00 0.44 (0.37, 0.53) 0.37 (0.30, 0.46) 0.51 (0.32, 0.81) 0.70 (0.25, 1.37) <0.001
Adjusted for age only 1.00 0.65 (0.54, 0.79) 0.60 (0.48, 0.74) 0.63 (0.39, 1.01) 0.78 (0.39, 1.55) <0.001
Adjusted ‡ 1.00 0.64 (0.51, 0.79) 0.63 (0.48, 0.82) 0.64 (0.36, 1.12) 0.85 (0.38, 1.88) 0.016
Further adjusted for BMI 1.00 0.65 (0.52, 0.82) 0.67 (0.51, 0.88) 0.74 (0.41, 1.30) 0.95 (0.40, 2.22) 0.092 §
Stroke
Cases 79 109 51 10 4
Unadjusted 1.00 0.41 (0.30, 0.54) 0.34 (0.24, 0.49) 0.67 (0.35, 1.30) 0.82 (0.30, 2.25) <0.001
Adjusted for age only 1.00 0.55 (0.41, 0.74) 0.51 (0.35, 0.73) 0.79 (0.41, 1.54) 0.89 (0.32, 2.48) 0.023
Adjusted ‡ 1.00 0.62 (0.44, 0.87) 0.54 (0.36, 0.83) 0.89 (0.42, 1.91) 1.31 (0.46, 3.71) 0.115 §
Further adjusted for BMI 1.00 0.61 (0.43, 0.86) 0.56 (0.36, 0.86) 0.94 (0.44, 2.02) 1.48 (0.52, 4.21) 0.201 §
Diabetes
Cases 197 297 119 12 5
Unadjusted 1.00 0.44 (0.37, 0.53) 0.32 (0.25, 0.40) 0.32 (0.18, 0.57) 0.40 (0.16, 0.99) <0.001
Adjusted for age only 1.00 0.54 (0.45, 0.66) 0.41 (0.32, 0.52) 0.35 (0.20, 0.65) 0.44 (0.18, 1.07) <0.001
Adjusted ‡ 1.00 0.58 (0.47, 0.72) 0.46 (0.35, 0.60) 0.57 (0.31, 1.04) 0.54 (0.20, 1.50) <0.001
Further adjusted for BMI 1.00 0.61 (0.48, 0.76) 0.54 (0.40, 0.72) 0.79 (0.43, 1.44) 0.89 (0.32, 2.46) 0.008
Gallstones
Cases 440 931 391 48 13
Unadjusted 1.00 0.61 (0.54, 0.69) 0.46 (0.40, 0.53) 0.56 (0.41, 0.76) 0.46 (0.26, 0.80) <0.001
Adjusted for age only 1.00 0.73 (0.65, 0.83) 0.58 (0.50, 0.66) 0.59 (0.43, 0.81) 0.49 (0.28, 0.86) <0.001
Adjusted ‡ 1.00 0.77 (0.67, 0.88) 0.64 (0.55, 0.76) 0.73 (0.52, 1.03) 0.46 (0.24, 0.92) <0.001
Further adjusted for BMI 1.00 0.78 (0.68, 0.90) 0.70 (0.59, 0.83) 0.85 (0.60, 1.22) 0.63 (0.32, 1.25) 0.002
Polyps
Cases 85 172 93 4 4
Unadjusted 1.00 0.60 (0.46, 0.77) 0.58 (0.43, 0.78) 0.25 (0.09, 0.67) 0.76 (0.28, 2.07) 0.001
Adjusted for age only 1.00 0.78 (0.60, 1.02) 0.80 (0.59, 1.09) 0.29 (0.10, 0.78) 0.62 (0.19, 1.97) 0.028
Adjusted ‡ 1.00 0.80 (0.58, 1.09) 0.83 (0.58, 1.19) 0.31 (0.10, 0.99) 0.85 (0.26, 2.79) 0.119
Further adjusted for BMI 1.00 0.81 (l.59, 1.11) 0.85 (0.59, 1.24) 0.34 (0.11, 1.09) 1.01 (0.31, 3.33) 0.206
Cancer
Cases 463 1175 671 72 20
Unadjusted 1.00 0.74 (0.66, 0.83) 0.77 (0.68, 0.87) 0.81 (0.63, 1.05) 0.68 (0.43, 1.09) 0.003
Adjusted for age only 1.00 0.89 (0.80, 1.00) 0.98 (0.86, 1.11) 0.91 (0.70, 1.19) 0.66 (0.40, 1.07) 0.632 §
Adjusted ‡ 1.00 1.01 (0.88, 1.15) 1.13 (0.97, 1.31) 0.95 (0.70, 1.29) 0.78 (0.46, 1.34) 0.366
Further adjusted for BMI 1.00 1.01 (0.88, 1.16) 1.15 (0.98, 1.33) 0.94 (0.68, 1.28) 0.84 (0.49, 1.44) 0.267
† Calculated using orthogonal polynomials; ‡ adjusted for age, vigorous physical activity category, dietary pattern, job category, and smoking status; § there was statistical significant
evidence for a quadratic or higher order trend.
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For chronic disease, there was a statistically significant linear trend for all models for the
prevalence of having a history of heart attack (unadjusted OR: 0.21 (95% CI: 0.05, 0.86), adjusted for
variables other than BMI OR: 0.28 (95% CI: 0.07, 1.15)), diabetes (unadjusted OR: 0.40 (95% CI: 0.16, 0.99)
and adjusted OR: 0.54 (95% CI: 0.20, 1.50)), and gallstones (unadjusted OR: 0.46 (95% CI: 0.26, 0.80)
and adjusted OR: 0.46 (95% CI: 0.24, 0.92)) (all p for linear trend ≤0.011).
For angina, although there was evidence of a linear trend for most models (all p for linear trend
<0.016 without adjusting for BMI), when the model was further adjusted for BMI, the linear trend
became a non-statistically significant tendency (p for linear trend = 0.092). A similar pattern was seen
for stroke, where there was evidence of a linear trend in the unadjusted and age-adjusted model,
which was no longer statistically significant after further adjustment (both p ≥ 0.115).
For polyps and cancer, although there was evidence of a linear trend where higher levels of nut
consumption was associated with lower prevalence of a history of these, in the unadjusted models
(both p ≤ 0.003) and adjusting for age for polyps (p = 0.028), this was no longer statistically significant
in the adjusted models (all p ≥ 0.119).
3.5. Nut Consumption and Nutrient Intake
As seen in Table 5, there was evidence of a linear trend for nutrients in all but one case for both
unadjusted and adjusted models. Total energy, fibre, and the percentage of energy from total fat,
monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA) were all higher amongst
those with higher levels of nut consumption. The percentage of energy from saturated fat was lower
amongst those with lower nut consumption in the adjusted model only. Likewise, the percentage of
energy from protein, carbohydrate, and total sugar was lower amongst those with higher levels of
nut consumption.
For the majority of micronutrients (exceptions being vitamins A and C), there was statistically
significant evidence of a linear trend in the models further adjusted for energy intake. However, both
vitamin A and vitamin C demonstrated quadratic trends where, although intakes were higher with
higher levels of nut consumption, the differences were less pronounced in successive nut intake
categories. For most micronutrients, intakes were higher for greater levels of nut consumption,
except for vitamin B12 which showed the opposite trend.
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Table 5. Nutrient intakes by nut consumption category.
Nutrient
Total Nut Consumption p for Linear
Trend
Unadjusted †,‡
p for Linear
Trend Adjusted
†,‡
p for Linear Trend
Further Adjusted for
Energy Intake †,‡
All Participants
(n = 34,831)
No Nuts
(n = 5631)
<Once per Week
(n = 17,992)
2–6 Times per Week
(n = 9887) Daily (n = 995) >Daily (n = 326)
Total energy (kJ) 9817 (9786, 9849) 9029 (8952, 9107) 9474 (9434, 9514) 10,565 (10,504, 10,624) 11,819 (11,610, 12,028) 13,596 (13,169, 14,023) <0.001 § <0.001§
Total fat (g) 84.7 (84.4, 85.0) 73.3 (72.5, 74.1) 80.3 (79.9, 80.8) 94.4 (93.8, 95.1) 112.3 (110.0, 114.6) 142.7 (137.2, 148.2) <0.001 § <0.001 §
%TE 32.4 (32.4, 32.5) 30.5 (30.3, 30.6) 32.0 (31.9, 32.1) 33.7 (33.6, 33.8) 35.9 (35.5, 36.2) 39.5 (38.8, 40.3) <0.001 § <0.001 §
Saturated fat (g) 29.3 (29.2, 29.4) 26.5 (26.1, 26.8) 28.5 (28.3, 28.7) 31.7 (31.4, 31.9) 33.8 (32.8, 34.7) 37.4 (35.6, 39.2) <0.001 § <0.001 §
%TE 11.1 (11.1, 11.1) 10.9 (10.8, 11.0) 11.2 (11.2, 11.2) 11.2 (11.1, 11.2) 10.6 (10.4, 10.8) 10.3 (9.9, 10.6) 0.938 § <0.001 §
Monounsaturated fat (g) 27.7 (27.6, 27.8) 23.4 (23.1, 23.6) 26.0 (25.9, 26.1) 31.2 (31.0, 31.4) 39.0 (38.2, 39.7) 52.9 (50.7, 55.2) <0.001 § <0.001 §
%TE 10.5 (10.5, 10.6) 9.7 (9.6, 9.7) 10.3 (10.3, 10.3) 11.1 (11.1, 11.2) 12.5 (12.3, 12.6) 14.7 (14.3, 15.1) <0.001 § <0.001 §
Polyunsaturated fat (g) 16.3 (16.2, 16.4) 13.4 (13.2, 13.6) 15.0 (14.9, 15.1) 18.8 (18.6, 18.9) 25.0 (24.5, 25.5) 36.2 (34.6, 37.8) <0.001 § <0.001 §
%TE 6.2 (6.2, 6.2) 5.6 (5.5, 5.6) 6.0 (6.0, 6.0) 6.7 (6.7, 6.8) 8.1 (8.0, 8.2) 10.1 (9.8, 10.4) <0.001 § <0.001 §
Protein (g) 89.3 (89.0, 89.6) 87.5 (86.8, 88.2) 87.7 (87.3, 88.1) 91.5 (91.0, 92.1) 98.1 (96.2, 100.0) 110.1 (106.4, 113.9) <0.001 § <0.001 §
%TE 15.1 (15.0, 15.1) 16.1 (16.0, 16.2) 15.3 (15.2, 15.3) 14.3 (14.3, 14.4) 13.8 (13.7, 13.9) 13.5 (13.3, 13.8) <0.001 § <0.001 §
Carbohydrate (g) 313 (312, 314) 297 (294, 300) 303 (302, 305) 322 (330, 335) 365 (358, 372) 394 (379, 409) <0.001 § <0.001 §
%TE 52.6 (52.6, 52.7) 54.2 (54.0, 54.4) 52.7 (52.6, 52.8) 51.9 (51.8, 52.1) 51.0 (50.6, 51.4) 48.2 (47.3, 49.1) <0.001 § <0.001 §
Sugar (g) 149 (148, 149) 142 (140, 144) 143 (142, 144) 157 (156, 159) 180 (176, 185) 199 (189, 208) <0.001 § <0.001 §
%TE 25.2 (25.2, 25.3) 26.2 (26.0, 26.4) 25.1 (25.1, 25.2) 24.8 (24.7, 24.9) 25.5 (25.1, 25.9) 24.3 (23.5, 25.0) <0.001 § <0.001 §
Fibre (g) 25.6 (25.5, 25.7) 23.6 (23.3, 23.9) 24.3 (24.1, 24.4) 28.0 (27.8, 28.2) 33.1 (32.3, 33.8) 39.5 (37.7, 41.3) <0.001 § <0.001 § 0.002 §
Vitamin A (µg) 1243 (1236, 1249) 1175 (1158, 1192) 1219 (1210, 1227) 1303 (1291, 1314) 1390 (1349, 1431) 1477 (1382, 1572) <0.001 § <0.001 § 0.340 §
Thiamin (mg) 3.13 (3.10, 3.15) 2.79 (2.72, 2.85) 2.94 (2.90, 2.97) 3.54 (3.48, 3.59) 3.94 (3.76, 4.13) 4.65 (4.28, 5.03) <0.001 § <0.001 § <0.001
Riboflavin (mg) 2.52 (2.51, 2.53) 2.48 (2.46, 2.50) 2.47 (2.46, 2.48) 2.58 (2.56, 2.60) 2.75 (2.69, 2.81) 2.94 (2.81, 3.06) <0.001 § <0.001 § <0.001 §
Vitamin B6 (mg) 2.82 (2.81, 2.83) 2.77 (2.74, 2.79) 2.75 (2.74, 2.76) 2.92 (2.90, 2.94) 3.19 (3.13, 3.25) 3.62 (3.48, 3.75) <0.001 § <0.001 § <0.001 §
Vitamin B12 (µg) 5.69 (5.66, 5.72) 5.93 (5.85, 6.01) 5.80 (5.75, 5.84) 5.44 (5.37, 5.50) 5.21 (4.99, 5.43) 4.76 (4.38, 5.15) <0.001 § <0.001 § <0.001 §
Folate (µg) 402 (401, 403) 384 (381, 388) 388 (386, 389) 426 (423, 429) 476 (466, 485) 550 (527, 573) <0.001 § <0.001 § <0.001 §
Vitamin C (mg) 171 (170, 172) 160 (158, 163) 164 (163, 165) 185 (184, 187) 206 (200, 212) 230 (213, 246) <0.001 § <0.001 § 0.664 §
Vitamin E (mg) 9.71 (9.66, 9.75) 8.19 (8.09, 8.29) 9.01 (8.96, 9.07) 11.09 (11.01, 11.18) 14.14 (13.84, 14.44) 18.74 (17.97, 19.52) <0.001 § <0.001 § <0.001 §
Calcium (mg) 1137 (1133, 1141) 1099 (1089, 1109) 1114 (1109, 1120) 1182 (1174, 1190) 1252 (1225, 1279) 1367 (1313, 1421) <0.001 § <0.001 § <0.001 §
Iron (mg) 18.8 (18.8, 18.9) 17.8 (17.5, 18.0) 18.2 (18.1, 18.3) 20.0 (19.9, 20.2) 22.7 (22.1, 23.2) 25.7 (24.6, 26.9) <0.001 § <0.001 § <0.001
Zinc (mg) 11.5 (11.4, 11.5) 11.0 (10.9, 11.1) 11.2 (11.1, 11.2) 11.9 (11.9, 12.0) 13.3 (13.1, 13.6) 15.6 (15.1, 16.2) <0.001 § <0.001 § <0.001 §
Values are presented as means (95% CI); † calculated using orthogonal polynomials; ‡ adjusted for age, vigorous physical activity category, dietary pattern, job category, and smoking status;
values with different superscript letters are significantly different in the adjusted model; § there was statistically significant evidence for a quadratic or higher order trend; TE, total energy.
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3.6. Effect Modification by Dietary Pattern
For body weight, there was evidence of between diet group differences in trends for increasing
nut frequency categories (interaction Wald p < 0.001) (as indicated by the non-parallel associations seen
in Figure 1a, Table 6). Among omnivores, for each higher nut consumption category, the linear trend
showed a 1.30 kg lower body weight (95% CI: 1.12, 1.48; p < 0.001) with a quadratic trend suggesting
an additional negative trend (p = 0.003) and no evidence for higher order trends (p ≥ 0.220 for both).
Among vegetarians, for those in each higher nut frequency category the linear trend shows a 0.73 kg
lower mean body weight (95% CI: 0.46, 1.01; p < 0.001). However, among vegans, for each higher
nut frequency category there was a non-statistically significant higher mean body weight by 0.87 kg
(95% CI: −0.29, 2.04; p = 0.141). The linear negative trend for omnivores was statistically significantly
greater than the trend in either vegetarians or vegans (both pairwise difference in trends p < 0.001)
and there was also a statistically significant difference in the linear trend between vegetarians and
vegans (p = 0.008).
For BMI, there was again evidence of an overall difference in trends between diet groups
(interaction Wald p < 0.001) (Figure 1b shows similar non-parallel slopes). Among omnivores, for each
higher nut consumption category there was a 0.54 unit lower BMI (95% CI: 0.47, 0.60; p < 0.001),
which was intensified in magnitude by a quadratic trend (p = 0.005). Among vegetarians, each higher
nut consumption category was associated with a linear 0.3 unit lower BMI (95% CI: 0.20, 0.39; p < 0.001)
further lowered by a statistically significant negative quadratic (p < 0.001), whereas for vegans, there
was a non-statistically significant 0.07 unit higher BMI per category (95% CI: −0.34, 0.49; p = 0.727)
and no evidence of a quadratic trend (p = 0.055). The linear trend for omnivores was statistically
significantly more negative than that seen in vegetarians (difference in trends p < 0.001) and vegans
(p = 0004), with no statistically significant difference between vegetarians and vegans (p = 0.087).
The magnitude of the decreasing quadratic trend was greater among vegetarians than omnivores
(p = 0.036).
For waist circumference, there was evidence of a difference in trends (interaction Wald p < 0.001)
and overall differences in linear (p < 0.001) and quadratic (p = 0.002) trends between diet groups
(Figure 1c). Among omnivores, for each higher nut frequency category, there was a 0.69 cm unit
lower mean waist circumference (95% CI: 0.54, 0.83; p < 0.001) with no evidence for higher order
trends (all p ≥ 0.099). Among vegetarians each higher nut frequency category was associated with
a non-statistically significant 0.13 cm lower mean waist circumference (95% CI: −0.36, 0.09; p = 0.241),
whereas among vegans the trend was in the opposite direction with a statistically significant 0.96 cm
higher mean waist circumference per category (95% CI: 0.01, 1.92; p = 0.047). The linear trend
in omnivores was statistically significantly different from the trend observed among vegetarians
(difference in trends p < 0.001) and vegans (p = 0.001) with a more negative quadratic trend evident
among vegetarians compared to omnivores (p = 0.001). However, the quadratic trend (p < 0.001) in
vegetarians dominated the linear trend, leading to lower waist circumferences for higher frequencies
of nut consumption in this group. The difference between vegetarians and vegans in the linear trend
was statistically significant (difference in trends p = 0.028), but not the quadratic trend (p = 0.704).
For the prevalence of having high blood cholesterol, the vegetarian and vegan groups were
combined because of the lack of any respondents reporting high cholesterol for all nut frequency
categories amongst the vegan group. There was evidence of an overall difference in trends between
omnivores and a combined vegetarian/vegan group (interaction Wald p = 0.005) with the difference
only evident for linear trends (Wald p = 0.004) and not for quadratic trends (p = 0.507), although there
was a small but statistically significant cubic trend (p = 0.015) (Figure 1d). Among omnivores, for each
greater nut frequency category, there was a non-statistically significant 4% lower odds of having high
cholesterol (95% CI: 0.91, 1.02; p = 0.228). Among the combined vegetarian and vegan group, the odds
were 19% lower for each higher category (95% CI: 0.73, 0.90; p < 0.001) but the cubic trend led to greater
odds in the highest nut frequency categories.
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Table 6. Effect modification of anthropometric and risk factor associations by dietary pattern.
Anthropometry/Risk
Factor Variable
Linear Trend * Quadratic Trend after Accounting for Linear Trend * All TrendsCombined *
Omnivores Vegetarians Vegans
p-Value for
between
Group
Difference
Omnivores Vegetarians Vegans
p-Value for
between
Group
Difference
p-Value for
between
Group
Difference
Weight (kg) −1.30 (−1.48, −1.12) −0.73 (−1.01, −0.46) 0.87 (−0.29, 2.04) <0.001 −0.28 (−0.46, −0.09) −0.53 (−0.79, −0.27) −1.08 (−2.20, 0.05) 0.133 <0.001
BMI (kg/m2) −0.54 (−0.60, −0.47) −0.30 (−0.39, −0.20) 0.07 (−0.34, 0.49) <0.001 −0.09 (−0.16, −0.03) −0.21 (−0.31, −0.12) −0.39 (−0.79, 0.01) 0.050 <0.001
Waist circumference (cm) −0.69 (−0.83, −0.54) −0.13 (−0.36, 0.09) 0.96 (0.01, 1.92) <0.001 −0.04 (−0.19, 0.11) −0.50 (−0.72, −0.29) −0.68 (−1.60, 0.24) 0.002 <0.001
High cholesterol † 0.96 (0.91, 1.02) 0.81 (0.73, 0.90) 0.004 1.02 (0.96, 1.09) 1.06 (0.96, 1.16) 0.507 0.005
* Adjusted for age, vigorous physical activity category, dietary pattern, job category, and smoking status; † effects are odds ratios rather than slopes.
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Figure 1. Association between frequency of nut con umption and predicted anthropom tric a d risk factors by ietary pattern. (a) Association between frequency of
nut consumption and body weight by dietary pattern; (b) association between frequency of nut consumption and BMI by dietary pattern; (c) association between
frequency of nut consumption and waist circumference by dietary pattern; (d) association between frequency of nut consumption and high blood cholesterol by
dietary pattern.
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There were also several overall differences of linear trends for a number of nutrients between
diet groups which are presented briefly and without discussion of higher order trends below. For the
percentage energy from total fat, saturated fat, monounsaturated fat, and polyunsaturated fat there
was an overall difference between diet groups (all pairwise p < 0.001). Among omnivores, vegetarians,
and vegans each higher nut frequency category was associated with a 1.4%, 1.9%, and 1.6% higher
mean percentage of energy derived from total fat (all p < 0.001). The positive association for vegetarians
was statistically significantly greater than for omnivores (p < 0.001).
For the percentage of energy from saturated fat, for each higher nut frequency category this
was 0.1% and 0.2% higher for omnivores and vegetarians respectively (both p < 0.001). Conversely,
for vegans, this was non-statistically significantly lower by 0.3% per nut consumption category
(p = 0.097). The trend was statistically significantly different between all diet groups (all pairwise
p ≤ 0.017).
For the percentage of energy from MUFA, for each higher nut frequency category was associated
with 0.7%, 0.9%, and 0.7% higher means for omnivores, vegetarians, and vegans respectively
(all p < 0.001). There was a statistically significant difference between omnivores and vegetarians
only (p < 0.001).
For the percentage of energy from PUFA, for each higher nut frequency category, the means
were 0.5%, 0.6%, and 0.9% greater for omnivores, vegetarians, and vegans respectively (all p < 0.001).
There was evidence that the trend was different between all diet groups (all pairwise p < 0.001).
Amongst those with higher nut consumption categories, statistically significantly higher intakes
were seen for protein among omnivores (4.5 g higher per category, p < 0.001), and vegetarians (3.8 g,
p < 0.001). There was a non-statistically significantly greater mean by 1.8 g among vegans for each
category (p = 0.187), with evidence of a difference between omnivores and vegan (p = 0.048).
For the percentage of energy from sugar there was also a statistically significant difference for
linear trend between diet groups (Wald p = 0.006). For omnivores, vegetarians, and vegans there
was a 0.4%, 0.7%, 1.0% higher percentage energy from sugar per higher category (all p ≤ 0.001).
The difference between omnivores and vegetarians only was statistically significant (p = 0.006).
In terms of micronutrients, there were statistically significant differences in linear trends between
diet groups for thiamine, vitamin B12, vitamin D, vitamin E, and calcium (all p < 0.001). For thiamine
this association was positive for both omnivores (p < 0.001) and vegans (p = 0.023), but not for
vegetarians (p = 0.307). For vitamin B12, each category higher nut frequency was associated with
higher values among omnivores (p < 0.001), but with a statistically significant lower value among
vegans (p = 0.010), and with no statistically significant difference among vegetarians (p = 0.411).
There was evidence for different trends between all diet groups (all pairwise p ≤ 0.019).
For Vitamin D, each higher nut intake category was associated with higher values among
omnivores (p < 0.001). There was no association for vegetarians and vegans. The trend was statistically
significantly different between omnivores and vegetarians (p ≤ 0.001).
For vitamin E, for each greater nut frequency category, there was a 1.2 mg, 1.4 mg, and 1.9 mg
higher mean for omnivores, vegetarians, and vegans respectively (all p < 0.001). The trend appeared to
differ between the three diet groups (all pairwise p ≤ 0.013).
For calcium there was a positive association with nut consumption categories for both omnivores
and vegetarians (both p < 0.001), but not for vegans (p = 0.874). There was evidence of different linear
trends between omnivores and vegetarians (p = 0.027), and between omnivores and vegans (p = 0.019).
4. Discussion
Examining the associations between nut intake and risk factors for chronic disease in this
population with diverse dietary patterns has provided us with important information on the
relationship between nut consumption and health. Higher nut consumption was associated with
lower BMI, waist circumference, and prevalence of both high cholesterol and high blood pressure.
In addition, higher nut consumption was associated with reduced prevalence of having had a heart
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attack, diabetes and gallstones. Greater nut intake was also associated with better diet quality overall.
Predictors of nut consumption included younger age, greater education level, higher employment
status, and more plant-based dietary categories. An understanding of these predictors can help target
public health messages to increase regular nut consumption as part of a cardioprotective diet.
A commonly reported barrier to nut consumption is the fear of weight gain because nuts are
high in fat and energy [44]. However, we found nut consumption was inversely associated with
body weight, BMI and waist circumference. These associations remained evident in models including
physical activity and energy intake. These findings replicate those found by previous epidemiology
studies which have reported that nut consumers are leaner than non-nut consumers [30–34]. Similarly,
when nuts are added to the diet in intervention studies, weight gain is not apparent, or is at least less
than predicted [34–39]. There have been several mechanisms for this finding discussed in the literature,
including the high satiety effects of nuts [45,46], increased metabolic rate due to the high unsaturated
fat content of nuts [47–49], and loss of metabolisable energy as faecal fat [50–52]. Given we found that
higher nut consumption was associated with a leaner body composition, and lower abdominal fat,
among a population with diverse dietary intakes, this adds to the evidence that fear of weight gain
with increased nut consumption is unfounded. Therefore, public health messages should emphasise
this point, and dispel such fears among the general population who are concerned that regular nut
consumption could result in unwanted weight gain.
There was evidence of a statistically significant linear trend where higher nut intake was associated
with a lower prevalence of high blood cholesterol. This finding is supported by numerous intervention
studies, which consistently report lower total and LDL cholesterol concentrations with greater nut
consumption [23]. The prevalence of having had a heart attack was also lower amongst those
with greater levels of nut consumption, a finding supported by numerous epidemiological studies,
which have reported inverse associations between nut consumption and CVD [4–9,11]. One mechanism
for these findings could be the higher intakes of unsaturated fat and lower intakes of saturated fat
observed amongst those with greater nut intakes in this cohort.
We found that with greater nut consumption, the prevalence of having high blood pressure was
lower. While some studies are in agreement with this finding [24], not all studies have reported such
an association [25]. Intervention studies have also produced equivocal findings [26,27]. Blood pressure
is an important risk factor for stroke. In this study the prevalence of having had a stroke was not
associated with nut intake. This is a finding congruent with a number of other studies [6,8,16].
Among this cohort of women, the prevalence of having been diagnosed with diabetes was lower
amongst those with higher nut intakes. Previous research in this area has also produced mixed results,
with one meta-analysis by Afshin et al. [53] reporting a small but significant reduction in the incidence
of type 2 diabetes with higher nut consumption, whereas a further three meta-analyses have reported
no association [8,15,16]. The inconsistent results could have resulted from lack of adjustment for BMI
by Afshin et al. [53]. In our study, although further adjustment for BMI attenuated the relationship
between nut intake and the incidence of diabetes, the association remained statistically significant, and
it is important to consider that BMI could both be a confounder of any such association and also be on
the causal pathway between nut consumption and diabetes. Possible mechanisms for a reduction in the
risk of developing type 2 diabetes from greater nut intakes are the higher intakes of monounsaturated
and polyunsaturated fats, which were evident in this cohort, using both absolute amounts and as a
percentage of total energy, for those with greater nut intakes. Higher intakes of these unsaturated fats
are associated with improvements in insulin sensitivity [54]. However, given the inconsistent findings
of research in this area to date, future carefully designed studies are required to address the possible
relationship between nut intake and the development of type 2 diabetes.
Diet quality was better amongst those with higher nut intakes. As mentioned above, nut intake
was associated with a more cardioprotective fat intake, namely, a higher percentage of energy from
cis-unsaturated fats, with a lower proportion from saturated fat. Greater levels of nut consumption
were also associated with a more nutrient-dense diet in terms of vitamins and minerals (except for
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vitamin A, C and B12), and also higher intakes of fibre, and lower intakes of sugar. The better nutrient
profile observed among nut consumers is consistent with both previous epidemiologic [19–21,55,56]
and intervention trials [39,57,58]. In fact, the results are remarkably similar to a NZ cross-sectional
study using a 24-h recall, which showed higher intakes of unsaturated fats, lower intakes of saturated
fat, higher intakes in most nutrients except for vitamin A and B12 [55]. This consistency is reassuring
given that the studies used different dietary assessment techniques and were conducted using data
from different populations.
In order to promote regular nut consumption, gaining some information on the factors associated
with nut intake is important. Predictors of greater intake in this UK cohort included older age,
more skilled job categories, higher levels of education, and more plant-based dietary patterns. Age has
been associated with nut consumption in other epidemiological studies [17,21], although differences
in age classification make comparisons difficult. In this cohort, nut consumption was negatively
associated with age but in a US study, the percentage of those consuming nuts was higher in those
aged over 51 years compared to those aged 19–51 years [21] and in a NZ sample, nut consumption was
significantly higher among those aged 31–70 years compared those aged 18–30 years [17]. Differences
in findings are likely to be due to differences in the age range studied. The UK cohort included
participants aged 35–70 years, whereas those in the NZ and USA studies had lower age limits of 18 and
19 years respectively.
Higher education and occupational status were associated with a higher likelihood of consuming
nuts. Education has also been positively associated with nut intake in NZ, Europe and the USA [17,21,59].
Education level and occupation can, with caution, be used as a rough proxy for socio-economic status
(SES). Studies in NZ and the USA have reported a higher prevalence of nut intake among those with
a higher SES [17]. Cost has been reported as a barrier to regular nut consumption [44]. Therefore public
health initiatives could consider promoting more affordable nuts such as peanuts, which have been
shown to improve health [11,35,56,60–63].
Those who were vegetarian or vegans were unsurprisingly more likely to consume nuts compared
to those who reported eating meat, a finding supported by previous research [18,22]. Vegetarians,
and in particular, vegans, are at higher risk of certain nutrient deficiencies compared to omnivores [64].
It is therefore reassuring that they consume more nuts, given that nuts are nutrient dense, and important
sources of protein, unsaturated fats and a number of vitamins and minerals including iron and zinc [65].
A novel finding of this study is that the benefits of higher levels of nut consumption appear
to be greater overall amongst omnivores than vegetarians and vegans, with vegans showing the
least benefits in terms of anthropometry outcomes with higher nut intakes and some suggestions
of potentially worse outcomes for the highest intake category (60 g per day and above) although
these should be interpreted with caution due to the small number of participants in this group.
This overall pattern may reflect generally healthier diets amongst non-omnivores with higher levels of
nut consumption being associated with smaller differences between the dietary groups. This differs
from the Seventh-Day Adventist results where statistically significant associations were observed for
both vegetarians and non-vegetarians (vegans were not independently examined), and while that study
did not investigate effect modification by dietary pattern, the protective gradient appeared steeper
in vegetarians [22]. If our results are confirmed, then where appropriate, public health messages
encouraging greater levels of nut consumption could be specifically targeted at omnivores, for example
by encouraging incorporating nuts into meat dishes as well as consuming them as a snack food. As this
is the largest dietary group in most western countries, and as the benefits from increasing intakes may
be greater within this group than for non-omnivores, such targeted interventions could maximise
the population–level impact from uptake of the intervention messages. The pattern of worsening
anthropometry measures amongst vegans with the highest levels of nut intake (60 g per day and
above) or having high cholesterol amongst vegetarians and vegans for the same high intake is also
novel although these differences between 60 g per day and no nuts for these diet groups was only
statistically significant for waist circumference (p = 0.045). Further research is needed as to whether
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this is a marker of particular vegan or vegetarian/vegan dietary patterns or whether this finding is
spurious. While consumption of nuts has been found to be associated with lower BMI in general
population surveys, such high intakes of nuts may not have the same association amongst vegans. It is
worth noting that vegans in this highest intake category did not appear to be consuming meaningfully
more nuts per day (88 g) than omnivores (85 g) or vegetarians (96 g) although these are all well above
common recommendations for nut intakes.
There are several limitations which should be considered when interpreting the results of this
study. Firstly, this was a cross-sectional analysis and so causal inference cannot be drawn, although
consistency between the data and plausible causal models can be examined. The preferable risk factor
profiles, and disease incidences observed amongst those with higher nut intakes might be due to
the addition of nutrient-dense nuts to the diet; however, an alternative explanation could be that
nut consumers are more health conscious. Thus, high nut consumption could also be a marker of
a healthier lifestyle and the observed associations could be the result of residual confounding by health
consciousness and associated health behaviours, despite the wide range of potential confounders
included in the adjusted analyses. We have not, for example, adjusted for physical activity or stress
and these could plausibly confound these associations. In general, the UKWCS was comprised of
participants who appeared health conscious, with relatively low rates of smoking and low BMI.
Additionally, this cohort included only females, and so results cannot be directly extrapolated to
males. Nut intake was assessed by FFQ, which tends to over-estimate the consumption of certain
foods [66]. However, the FFQ used has been validated against a semi-weighed four-day food dairy
and biomarkers of intake [41]. In addition, a strength of this study is diverse nature of the population
in terms of dietary patterns resulting in the wider range in nut intake than seen in other research,
which reduces estimation error [67,68].
5. Conclusions
In conclusion, higher nut intakes in this cohort, which comprised participants with diverse dietary
patterns, were associated with a lower prevalence of having diabetes, gallstones, and a heart attack.
Better risk profiles from lower BMI, abdominal fat, blood cholesterol and blood pressure could account
for these observed reductions. Further, the better diet quality observed amongst those with higher nut
intakes, in particular with the type of fat, are likely to contribute to the protective effects of regular nut
consumption. Predictors of nut intakes included age, education level and employment status, which
are relatively consistent with other studies. The associations of more positive markers of health with
higher levels of nut intake appear to be greatest for omnivores, followed by vegetarians, and least,
and negatively associated in one case, for vegans. These predictors should be used to guide future
health messages aimed at increasing regular nut consumption, especially amongst omnivores.
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